These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
684 related articles for article (PubMed ID: 32171074)
1. Comorbidities and multi-organ injuries in the treatment of COVID-19. Wang T; Du Z; Zhu F; Cao Z; An Y; Gao Y; Jiang B Lancet; 2020 Mar; 395(10228):e52. PubMed ID: 32171074 [No Abstract] [Full Text] [Related]
2. Angiotensin receptor blockers for the treatment of COVID-19 and its comorbidities. Saavedra JM Pharmacol Res; 2020 Sep; 159():104958. PubMed ID: 32473311 [No Abstract] [Full Text] [Related]
3. The impact of hydroxychloroquine shortages on patients with dermatological conditions during COVID-19 pandemic. Shah M; Sachdeva M; Dodiuk-Gad RP Dermatol Ther; 2020 Jul; 33(4):e13524. PubMed ID: 32383251 [No Abstract] [Full Text] [Related]
4. Impact of Hydroxychloroquine on Antibody Responses to the SARS-CoV-2 Coronavirus. de Miranda Santos IKF; Costa CHN Front Immunol; 2020; 11():1739. PubMed ID: 32849619 [No Abstract] [Full Text] [Related]
5. [Thinking on clinical rational use of TCM injection in the treatment of novel coronavirus pneumonia (COVID-19)]. Wang ZF; Wang YP; Zhang HM; Fan YP; Lü C; Wang YY Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(14):1044-1047. PubMed ID: 32294864 [TBL] [Abstract][Full Text] [Related]
7. Just a little bit more patience…. Montravers P; de Tymowski C; Assadi M; Yung S; Kantor E Anaesth Crit Care Pain Med; 2020 Jun; 39(3):383-384. PubMed ID: 32405519 [No Abstract] [Full Text] [Related]
8. Clinical trials for the treatment of Coronavirus disease 2019 (COVID-19): A rapid response to urgent need. Zhang T; He Y; Xu W; Ma A; Yang Y; Xu KF Sci China Life Sci; 2020 May; 63(5):774-776. PubMed ID: 32124179 [No Abstract] [Full Text] [Related]
9. Could Chloroquine /Hydroxychloroquine Be Harmful in Coronavirus Disease 2019 (COVID-19) Treatment? Guastalegname M; Vallone A Clin Infect Dis; 2020 Jul; 71(15):888-889. PubMed ID: 32211771 [No Abstract] [Full Text] [Related]
10. On the use of corticosteroids for 2019-nCoV pneumonia. Shang L; Zhao J; Hu Y; Du R; Cao B Lancet; 2020 Feb; 395(10225):683-684. PubMed ID: 32122468 [No Abstract] [Full Text] [Related]
11. The looming pandemic of COVID-19: What therapeutic options do we have now? Afsar NA J Chin Med Assoc; 2020 May; 83(5):508-509. PubMed ID: 32221153 [No Abstract] [Full Text] [Related]
12. The course of clinical diagnosis and treatment of a case infected with coronavirus disease 2019. Han W; Quan B; Guo Y; Zhang J; Lu Y; Feng G; Wu Q; Fang F; Cheng L; Jiao N; Li X; Chen Q J Med Virol; 2020 May; 92(5):461-463. PubMed ID: 32073161 [No Abstract] [Full Text] [Related]
14. [Cardiovascular safety of hydroxychloroquine in the COVID-19 pandemic]. Bozzo R; Ibelli F; Scublinsky D Medicina (B Aires); 2020; 80 Suppl 3():89-90. PubMed ID: 32658855 [No Abstract] [Full Text] [Related]
15. [Expert consensus on the use of corticosteroid in patients with 2019-nCoV pneumonia]. Zhao JP; Hu Y; Du RH; Chen ZS; Jin Y; Zhou M; Zhang J; Qu JM; Cao B Zhonghua Jie He He Hu Xi Za Zhi; 2020 Mar; 43(3):183-184. PubMed ID: 32164084 [No Abstract] [Full Text] [Related]
16. Asthma and COVID-19: Is asthma a risk factor for severe outcomes? Johnston SL Allergy; 2020 Jul; 75(7):1543-1545. PubMed ID: 32358994 [No Abstract] [Full Text] [Related]